Ontology highlight
ABSTRACT: Purpose
The objective of this study was to elucidate the characteristics and mechanism of formation of the fusion plasmid pHNSHP24 carrying mcr-1.1.Materials and methods
mcr-1.1-bearing Escherichia coli SHP24 and the corresponding transconjugant were subjected to whole-genome sequencing (WGS) combining the Illumina and MinION platforms to obtain the complete sequences of the fusion plasmid and its original plasmids.Results
Complete sequence analysis and S1 nuclease-pulsed field gel electrophoresis (S1-PFGE) results indicated that E. coli SHP24 carried four plasmids: mcr-1.1-harboring phage-like plasmid pHNSHP24-3, F53:A-:B- plasmid pHNSHP24-4, pHNSHP24-1, and pHNSHP24-2. However, the plasmid pHNSHP24 carrying mcr-1.1 presents in the transconjugant differed from the four plasmids in the donor strain SHP24. Further analysis showed that pHNSHP24 may be the fusion product of pHNSHP24-3 and pHNSHP24-4 and is formed through a replicative transposition mechanism mediated by IS26 in E. coli SHP24.Conclusion
This study is the first to report the fusion of an mcr-1.1-harboring phage-like pO111 plasmid and an F53:A-:B- plasmid mediated by IS26. Our findings revealed the role of phage-like and fusion plasmids in the dissemination of mcr-1.1.
SUBMITTER: Wu R
PROVIDER: S-EPMC9748602 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
Wu Renjie R Lv Luchao L Wang Chengzhen C Gao Guolong G Yu Kaiyang K Cai Zhongpeng Z Liu Yiyun Y Yang Jun J Liu Jian-Hua JH
Infection and drug resistance 20221209
<h4>Purpose</h4>The objective of this study was to elucidate the characteristics and mechanism of formation of the fusion plasmid pHNSHP24 carrying <i>mcr-1.1</i>.<h4>Materials and methods</h4><i>mcr-1.1</i>-bearing <i>Escherichia coli</i> SHP24 and the corresponding transconjugant were subjected to whole-genome sequencing (WGS) combining the Illumina and MinION platforms to obtain the complete sequences of the fusion plasmid and its original plasmids.<h4>Results</h4>Complete sequence analysis a ...[more]